Form 8-K · Current report
Steris 8-K, filed Nov 4, 2026
- Filed
- CIK
- 0001757898
- Accession no.
- 0001628280-26-070220
Summary
STERIS reported fiscal 2027 second-quarter revenue of $1.6 billion, up 9% from a year earlier with 8% constant-currency organic growth, and raised its full-year adjusted earnings guidance to $11.35–$11.55 per diluted share from $11.10–$11.30, citing stable underlying performance plus the benefit of tariff refunds. The company also approved a targeted restructuring plan, primarily in its Healthcare segment, with expected charges of about $45 million and annualized savings of about $9 million.
Key points
- Second-quarter net income was $213.7 million, or $2.19 per diluted share, versus $191.9 million, or $1.94 per diluted share, a year earlier; adjusted EPS was $2.94 versus $2.47.
- Segment revenue: Healthcare rose 9% to $1.1 billion, Applied Sterilization Technologies rose 5% to $295.6 million, and Life Sciences rose 18% to $170.6 million.
- Tariff refunds received year-to-date benefited pre-tax results by about $20 million and account for about $0.18 of the revised EPS outlook; gross tariff costs were flat at $15 million for the quarter.
- The restructuring plan includes facility realignment, product rationalization and organizational changes, with about $25 million of charges recorded in the quarter and the full savings expected in fiscal years after 2028.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 2.05Costs Associated with Exit or Disposal Activities
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On November 4, 2026, STERIS plc (the “Company” or "STERIS") issued a press release announcing its financial results for the quarter ended September 30, 2026. A copy of this press release is attached hereto as Exhibit 99.1. The information contained in this Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished to the Securities and Exchange Commission and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liabilities of that Section. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.